160 related articles for article (PubMed ID: 21055434)
1. Synthesis and antinociceptive effects of endomorphin-1 analogs with C-terminal linked by oligoarginine.
Wang CL; Guo C; Wang YQ; Zhou Y; Li Q; Ni JM; Wang R
Peptides; 2011 Feb; 32(2):293-9. PubMed ID: 21055434
[TBL] [Abstract][Full Text] [Related]
2. Endomorphin-1 analogs with oligoarginine-conjugation at C-terminus produce potent antinociception with reduced opioid tolerance in paw withdrawal test.
Yuan BY; Liu WZ; Wang XF; Zhang YZ; Yang DJ; Wang CL
Peptides; 2018 Aug; 106():96-101. PubMed ID: 30016700
[TBL] [Abstract][Full Text] [Related]
3. Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1.
Liu HM; Liu XF; Yao JL; Wang CL; Yu Y; Wang R
J Pharmacol Exp Ther; 2006 Oct; 319(1):308-16. PubMed ID: 16803861
[TBL] [Abstract][Full Text] [Related]
4. Novel endomorphin-1 analogs with C-terminal oligoarginine-conjugation display systemic antinociceptive activity with less gastrointestinal side effects.
Wang CL; Qiu TT; Diao YX; Zhang Y; Gu N
Biochimie; 2015 Sep; 116():24-33. PubMed ID: 26115815
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
[TBL] [Abstract][Full Text] [Related]
6. Characterization of opioid activities of endomorphin analogs with C-terminal amide to hydrazide conversion.
Wang CL; Ren YK; Xiang Q; Wang Y; Gu N; Lu C; Wang R
Neuropeptides; 2013 Oct; 47(5):297-304. PubMed ID: 24084335
[TBL] [Abstract][Full Text] [Related]
7. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
[TBL] [Abstract][Full Text] [Related]
8. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
[TBL] [Abstract][Full Text] [Related]
9. Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2.
Li T; Fujita Y; Tsuda Y; Miyazaki A; Ambo A; Sasaki Y; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y
J Med Chem; 2005 Jan; 48(2):586-92. PubMed ID: 15658871
[TBL] [Abstract][Full Text] [Related]
10. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo characterization of opioid activities of C-terminal esterified endomorphin-2 analogs.
Wang CL; Guo C; Zhou Y; Wang R
Peptides; 2009 Sep; 30(9):1697-704. PubMed ID: 19520129
[TBL] [Abstract][Full Text] [Related]
12. Endomorphin-2 analogs with C-terminal esterification produce potent systemic antinociception with reduced tolerance and gastrointestinal side effects.
Wang CL; Qiu TT; Yang DJ; Yuan BY; Han FT; Li L; Gu N
Neuropharmacology; 2017 Apr; 116():98-109. PubMed ID: 28042019
[TBL] [Abstract][Full Text] [Related]
13. Conformationally constrained deltorphin analogs with 2-aminotetralin-2-carboxylic acid in position 3.
Tóth G; Darula Z; Péter A; Fülöp F; Tourwé D; Jaspers H; Verheyden P; Böcskey Z; Tóth Z; Borsodi A
J Med Chem; 1997 Mar; 40(6):990-5. PubMed ID: 9083489
[TBL] [Abstract][Full Text] [Related]
14. Endomorphin 1[psi] and endomorphin 2[psi], endomorphins analogues containing a reduced (CH2NH) amide bond between Tyr1 and Pro2, display partial agonist potency but significant antinociception.
Zhao QY; Chen Q; Yang DJ; Feng Y; Long Y; Wang P; Wang R
Life Sci; 2005 Jul; 77(10):1155-65. PubMed ID: 15878600
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
16. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
17. Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice.
Li SR; Wang T; Wang R; Dai X; Chen Q; Li RD
Brain Res; 2005 May; 1043(1-2):132-8. PubMed ID: 15862526
[TBL] [Abstract][Full Text] [Related]
18. Opioid receptor affinity and analgesic activity of O- and C-glycosylated opioid peptides.
Negri L; Melchiorri P; Rocchi R; Scolaro B
Acta Physiol Hung; 1996; 84(4):441-3. PubMed ID: 9328626
[TBL] [Abstract][Full Text] [Related]
19. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs.
Janecka A; Fichna J; Kruszynski R; Sasaki Y; Ambo A; Costentin J; do-Rego JC
Biochem Pharmacol; 2005 Dec; 71(1-2):188-95. PubMed ID: 16288997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
